Neuronetics, Inc.
USD1.56
-0.11 (-6.59%)
CEO
Daniel L. Reuvers
IPO Date
2018-06-28
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ
Country
US
Open
$1.67
Prev. Close
$1.67
Day Low
$1.56
Day High
$1.69
52W Low
$0.80
52W High
$4.85
Market Cap
$0.11B
Volume
1.07M
| 30,000 |
| $0.00 |
| 29 May 2026 | Cucuz Sasha | director | A-Award | Acquired | 30,000 | $0.00 |
| 29 May 2026 | CONLEY SHERYL L | director | A-Award | Acquired | 30,000 | $0.00 |
| 29 May 2026 | CASCELLA ROBERT | director | A-Award | Acquired | 36,250 | $0.00 |
| 29 May 2026 | Amin Avinash | director | A-Award | Acquired | 30,000 | $0.00 |
| 21 May 2026 | Pfanstiel Steven | Former EVP, CFO and Treasurer | S-Sale | Disposed | 8,569 | $1.34 |
| 20 May 2026 | Chernett Jorey | 10 percent owner | P-Purchase | Acquired | 100,000 | $1.17 |
| 13 May 2026 | BROWN FRANCIS X III | Interim PAO | Disposed | 0 | $0.00 |
| 13 May 2026 | Chernett Jorey | 10 percent owner | P-Purchase | Acquired | 475,000 | $1.34 |